<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:department>Sch of Social Sciences</gtr:department><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/9C10D78F-6430-4CA7-9528-B96B0762A4C6"><gtr:id>9C10D78F-6430-4CA7-9528-B96B0762A4C6</gtr:id><gtr:name>Cardiff University</gtr:name><gtr:address><gtr:line1>Research &amp; Consultancy</gtr:line1><gtr:line2>PO Box 923</gtr:line2><gtr:line4>Cardiff</gtr:line4><gtr:line5>South Glamorgan</gtr:line5><gtr:postCode>CF10 3TE</gtr:postCode><gtr:region>Wales</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/451F0A24-8F12-4BA4-8EEF-70E151767FB5"><gtr:id>451F0A24-8F12-4BA4-8EEF-70E151767FB5</gtr:id><gtr:firstName>Rebecca</gtr:firstName><gtr:otherNames>Elizabeth Cara</gtr:otherNames><gtr:surname>Dimond</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=ES%2FK00901X%2F1"><gtr:id>64CE310B-B4B5-4717-9C4D-9A9527BD4340</gtr:id><gtr:title>Patient and professional understandings of risk: how complexity and uncertainty of genetic knowledge impacts on reproductive decision making</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>ES/K00901X/1</gtr:grantReference><gtr:abstractText>&lt;p>This fellowship examines how patients with mitochondrial disease make reproductive decisions in the context of emerging IVF technologies. Mitochondria are small energy producing structures contained in the cytoplasm of a cell, and are inherited through the female line. Scientists at the Wellcome Trust Centre for Mitochondrial Research in Newcastle have developed processes involving ?mitochondria donation?, which potentially give women with mitochondrial disease the opportunity to have their own, healthy children. But these pioneering 'germ line' techniques have challenged existing legal and ethical frameworks, attracted intense media interest and prompted national public consultations.&lt;/p>

&lt;p>Accounts of mitochondrial donation, particularly within media coverage, assume a level of technological determinism, that if these techniques are available then this will 'eliminate' mitochondrial disease from families. Ultimately, future use will depend on how patients and families experience health and illness and how they assess complex risk information.&lt;/p>

&lt;p>&amp;nbsp;&lt;/p>

&lt;p>Female patients of reproductive age and their partners, and scientists and clinicians will be interviewed to explore the kinds of risks associated with mitochondrial disease and examine the implications of these contemporary advances. Finally, patient and scientific conferences will be observed to examine how genetic risk and reproductive solutions are represented at public events.&lt;/p></gtr:abstractText><gtr:potentialImpactText>Patients and families with mitochondrial disease

This research will identify how patients and families assess genetic risk, negotiate the boundaries of health and illness, and identify current and future roles for genetic technologies. This research focuses on a critical stage for families, when support needs are high but as yet remain unidentified. Patients can often be marginalised through the privileging of professional accounts (Gillman et al., 2000) and this research will provide a route through which their concerns can be voiced and addressed. Patients will be provided with a voice in the research process. In the medium term, patient groups will benefit from communication of this knowledge to the mitochondrial disease centres. In the long term, patients will benefit from a greater clinical and public awareness of the considerable burdens experienced by patients, not just in managing disease but also in negotiating the choice and responsibilities associated with reproductive technologies. 

Rare disease groups 

Rare disease leads to great inequalities in terms of accessing healthcare, support and expertise. For patients, carers and family members, this can be an incredibly isolating experience (Dimond, 2011). This research will not just highlight the social and biological implications of mitochondrial disease as a specific rare disease, but through collaboration with Genetic Alliance, an organisation which has an impressive record working with rare and genetic disease groups, this presents a realistic opportunity to change the way in which rare disease in general, is managed in the UK.

Mitochondrial Disease Services Team

This research is supported by Professor Turnbull and Professor Poulton who are experts in mitochondrial disease management and both anticipate that this research will have a significant impact on their work. Both have identified the lack of knowledge of how patients and their families respond to genetic risk, as problematic in providing and planning patient services. This will be particularly important in the translation of reproductive technologies from bench to bedside. Ongoing contact with these centres of mitochondrial expertise will ensure that the research remains closely aligned, and has maximum relevence, to the work of the clinic and in their engagement with patients.

Policy makers

Emerging techniques of mitochondrial donation have challenged legal and ethical frameworks, bringing policy makers and stakeholders into a publically contested domain. This research will provide empirical evidence about the implications of novel technologies and significantly, will provide an indication of future use and demand, for reproductive assistance. Identifying how patients with rare and complex disease negotiate genetic risk has relevence across patient groups. The proposed research will be conducted soon after publication of the results from the HFEA public consultation which means optimum potential for informing this debate and bringing clarity on key issues for policy makers.

Health Professionals and publics 

A long term legacy of this project which has impact beyond the immediate mitochondrial community is the preparation of tools for professional education and public engagement. Collaboration with the Genomics Policy Unit will contribute to educational resources for health professionals, expanding professional knowledge of how mitochondrial disease is negotiated by patients and families as both a risk to health and to future generations. The ideas raised through media coverage, focus groups and interviews with patients and professionals about future technologies will be transformed into a tool or game to prompt public discussion, in collaboration with established public engagement groups.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/924BE15C-91F2-4AAD-941A-3F338324B6AE"><gtr:id>924BE15C-91F2-4AAD-941A-3F338324B6AE</gtr:id><gtr:name>ESRC</gtr:name></gtr:funder><gtr:start>2014-01-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>189172</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>70343A8A-68E6-45EE-A66C-CA6620298119</gtr:id><gtr:title>The public shaping of medical research: patient associations, health movements and biomedicine</gtr:title><gtr:parentPublicationTitle>New Genetics and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6826ab221b9aa4c369c13bc2ad21643"><gtr:id>b6826ab221b9aa4c369c13bc2ad21643</gtr:id><gtr:otherNames>Dimond R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>56d49078d1e199.30464790</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5DF85A0-5981-4B6B-8097-4A46C33AD1F5</gtr:id><gtr:title>Three persons, three genetic contributors, three parents: Mitochondrial donation, genetic parenting and the immutable grammar of the 'three x x'.</gtr:title><gtr:parentPublicationTitle>Health (London, England : 1997)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6826ab221b9aa4c369c13bc2ad21643"><gtr:id>b6826ab221b9aa4c369c13bc2ad21643</gtr:id><gtr:otherNames>Dimond R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1363-4593</gtr:issn><gtr:outcomeId>5aaa7e68a54658.46088082</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0F20EA8-AB87-4BB3-B440-FC4B7E90FCA3</gtr:id><gtr:title>Techniques of donation: 'three parents', anonymity and disclosure</gtr:title><gtr:parentPublicationTitle>Journal of Medical Law and Ethics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6826ab221b9aa4c369c13bc2ad21643"><gtr:id>b6826ab221b9aa4c369c13bc2ad21643</gtr:id><gtr:otherNames>Dimond R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:outcomeId>56d490084d2c47.90071662</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>14AF59A0-E9D6-4922-8674-07A2C5547C70</gtr:id><gtr:title>Social and ethical issues in mitochondrial donation.</gtr:title><gtr:parentPublicationTitle>British medical bulletin</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6826ab221b9aa4c369c13bc2ad21643"><gtr:id>b6826ab221b9aa4c369c13bc2ad21643</gtr:id><gtr:otherNames>Dimond R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0007-1420</gtr:issn><gtr:outcomeId>56d48fd3680597.53204612</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C5CBDB42-BEA8-443A-A1D7-FEEA38DE89FE</gtr:id><gtr:title>Mitochondrial donation, patient engagement and narratives of hope.</gtr:title><gtr:parentPublicationTitle>Sociology of health &amp; illness</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e80ece512145cc740eaa4e442326fe7"><gtr:id>9e80ece512145cc740eaa4e442326fe7</gtr:id><gtr:otherNames>Herbrand C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0141-9889</gtr:issn><gtr:outcomeId>5a350d0caecb22.24635842</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1A3DB6B9-D212-42DC-801F-F42F9C04DA6A</gtr:id><gtr:title>Comment on mitochondrial replacement techniques and the birth of the 'first'</gtr:title><gtr:parentPublicationTitle>Journal of Law and the Biosciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6826ab221b9aa4c369c13bc2ad21643"><gtr:id>b6826ab221b9aa4c369c13bc2ad21643</gtr:id><gtr:otherNames>Dimond R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa7de87cac17.02109882</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6E07F092-6A9D-462C-90B6-FFB0A95FC277</gtr:id><gtr:title>Debating CRISPR/cas9 and Mitochondrial Donation: Continuity and Transition Performances at Scientific Conferences</gtr:title><gtr:parentPublicationTitle>Engaging Science, Technology, and Society</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eb6a5d8549b3d538383aa12679a5a486"><gtr:id>eb6a5d8549b3d538383aa12679a5a486</gtr:id><gtr:otherNames>Stephens N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5875f65ae21150.20020630</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3D00CFB2-EF06-406C-AC30-4086E7A4F375</gtr:id><gtr:title>Paul Atkinson Festschrift</gtr:title><gtr:parentPublicationTitle>Qualitative Research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b6826ab221b9aa4c369c13bc2ad21643"><gtr:id>b6826ab221b9aa4c369c13bc2ad21643</gtr:id><gtr:otherNames>Dimond R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:outcomeId>5aaa7e2ad12452.44684012</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">ES/K00901X/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>E88ECDEE-D58E-417E-A379-9FBB35647A90</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Science and Technology Studies</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>5BECA85F-CCD1-43D9-9B33-FFDFF6377498</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Med Soc/Soc Health &amp; Illness</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E88ECDEE-D58E-417E-A379-9FBB35647A90</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Science and Technology Studies</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>E420B429-253A-4597-91E9-199D86682755</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Social Theory</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>F0322ED6-113F-4530-BA5E-562216587E68</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Sociology</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>33A50DE3-0023-4F8B-810C-F0B929F9218F</gtr:id><gtr:percentage>0</gtr:percentage><gtr:text>Womens and Gender Studies</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>